GM
55
6
DE
49
3
URBN
67
3
MPC
28
3
SWK
53
4
ETN
64
4
AMP
43
2
HIG
48
5
SLG
37
6
MET
58
2
AMGN
42
14
CNP
59
17
CMS
57
2
CNX
67
4
RRC
52
2
ILMN
31
4
HPQ
55
3
ACN
54
2
MAT
41
2
SRE
37
9
GM
55
6
DE
49
3
URBN
67
3
MPC
28
3
SWK
53
4
ETN
64
4
AMP
43
2
HIG
48
5
SLG
37
6
MET
58
2
AMGN
42
14
CNP
59
17
CMS
57
2
CNX
67
4
RRC
52
2
ILMN
31
4
HPQ
55
3
ACN
54
2
MAT
41
2
SRE
37
9
Financhill
Back

Constellium SE 10K Form

Sell
50

CSTM
Constellium SE

Last Price:
$10.27
Seasonality Move:
3.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CSTM News And Ratings

See the #1 stock for the next 7 days that we like better than CSTM

CSTM Financial Statistics

Sales & Book Value

Annual Sales: $7.8B
Cash Flow: $-9.6M
Price / Cash Flow: 13.14
Annual Sales: $6.87
Price / Book: 1.5

Profitability

EPS (TTM): 0.73370
Net Income (TTM): $106.8M
Gross Margin: $768.7M
Return on Equity: 10.74%
Return on Assets: 2.05%

Constellium SE Earnings Forecast

Key Constellium SE Financial Ratios

  • The Gross Profit Margin over the past 13 years for CSTM is 9.81%.
  • The Selling, General & Administrative Expenses for CSTM have been equal to 4.17% of Gross Profit Margin.
  • The Research & Development expenses have been 0.72% of Revenue.
  • The Interest Expense is 92.00% of Operating Income.
  • The Net Earning history of CSTM is 1.73% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 5 years.

Constellium SE Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Metals & Mining
Sector: Materials
Current Symbol: CSTM
CUSIP: N22035
Website: constellium.com

Debt

Debt-to-Equity Ratio: 2.03
Current Ratio: 1.28
Quick Ratio: 0.52

Price-to-Earnings

Trailing P/E Ratio: 11.34
Forward P/E Ratio: 6.25

CSTM Technical Analysis vs Fundamental Analysis

Sell
50
Constellium SE (CSTM) is a Sell

Is Constellium SE a Buy or a Sell?

  • Constellium SE stock is rated a Sell
    The current Constellium SE [CSTM] share price is $10.31. The Score for CSTM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.